Incidence of obesity does not appear to be increased after treatment of acute lymphoblastic leukemia in Brazilian children: Role of leptin, insulin, and IGF-1

Hormone Research

Volumn 68, Issue 4, 2007, Pages 164-170

  Papadia, Carla ^a   Naves, Luciana A ^a   Costa, Sandra S S ^b   Vaz, Janete A R ^b   Domingues, Lucilia ^a   Casulari, Luiz Augusto ^c,d  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Sabin Laboratory   (Brazil)

^c HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

^d Ed America Office Tower ^*  (Brazil)

Author keywords

IGF 1; Insulin; Leptin; Leukemia; Obesity

Indexed keywords

ANTINEOPLASTIC AGENT; INSULIN; LEPTIN; SOMATOMEDIN; SOMATOMEDIN C;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; BRAZIL; CANCER SURVIVAL; CHEMICAL ANALYSIS; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MALE; METABOLISM; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ACUTE LYMPHOCYTIC LEUKEMIA; BLOOD; COMPARATIVE STUDY; FOLLOW UP; INCIDENCE; PHYSIOLOGY; WAIST HIP RATIO;

ADOLESCENT; BODY MASS INDEX; BRAZIL; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INSULIN; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; OBESITY; WAIST-HIP RATIO;

EID: 35248888161     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100781     Document Type: Article

References (53)

1. Argüelles B, Barrios V, Buño M, Madero L, Argente J: Anthropometric parameters and their relationship to serum growth hormone-binding protein and leptin levels in children with acute lymphoblastic leukaemia: a prospective study. Eur J Endocrinol 2000;143:243-250.
2. Reilly JJ, Kelly A, Ness P, Dorosty AR, Wallace WHB, Gibson BES, Emmett PM, ALSPAC Study Team: Premature adiposity rebound in children treated for acute lymphoblastic leukemia. J Clin Endocrinol Metab 2001;86:2775-2778.
3. Odame I, Reilly JJ, Gibson BES, Donaldson MDC: Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child 1994;71:147-149.
4. Zee P, Chen CH: Prevalence of obesity in children after therapy for acute lymphoblastic leukaemia. Am J Pediatr Hematol Oncol 1986;8:294-299.
5. Schell MJ, Ochs JJ, Schrock EA, Carter M: A method of predicting adult height and obesity in long term survivors of childhood acute lymphoblastic leukaemia. J Clin Oncol 1992;10:128-133.
6. Davies HA, Didcock E, Didi M, Ogilvy-Stuart A, Wales JKH, Shalet SM: Growth, puberty and obesity after treatement for leukaemia. Acta Paediatr 1995;411(Suppl):45-50.
7. Mayer EI, Reuter M, Dopfer RE, Ranke MB: Energy expenditure, energy intake and prevalence of obesity after therapy for acute lymphoblastic leukemia during childhood. Horm Res 2000;53:193-199.
8. Birkebaek NH, Clausen N: Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia. Arch Dis Child 1998;79:161-164.
9. Didi M, Didcock E, Davies HA, Ogilvy-Stuart AL, Wales JKH, Shalet SM: High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia during childhood. J Pediatr 1995;127:63-67.
10. Brennan BMD, Rahim A, Blum WF, Adams JA, Eden OB, Shalet SM: Hyperleptinaemia in young adults following cranial irradiation in childhood: growth hormone deficiency or leptin insensitivity? Clin Endocrinol 1999;50:163-169.
11. Nysom K, Holm K, Michaelsen KF, Hertz H, Muller J, Molgaard C: Degree of fatness after treatment for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 1999;84:4591-4596.
12. Büllow B, Link K, Ahren B, Nilsson A-S, Erfurth EM: Survivors of childhood acute lymphoblastic leukaemia, with radiation-induced GH deficiency, exhibit hyperleptinaemia and impaired insulin sensitivity, unaffected by 12 months of GH treatment. Clin Endocrinol 2004;61:683-691.
13. Craig F, Leiper AD, Stanhope R, Brain C, Meller ST, Nussey SS: Sexually dimorphic and radiation dose dependent effect of cranial irradiation on body mass index. Arch Dis Child 1999;81:500-504.
14. Oeffinger KC, Mertens AC, Sklar CA, Yasui Y, Fears T, Stovall M, Vik TA, Inskip PD, Robison LL: Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the childhood cancer survivor study. J Clin Oncol 2003;21:1359-1365.
15. Groot-Loonen JJ, Otten BJ, van't Hof MA, Lippens RJ, Stoelinga GB: Influence of treatment modalities on body weight in acute lymphoblastic leukemia. Med Pediatr Oncol 1996;27:92-97.
16. Birkebaek NH, Fisker S, Clausen N, Tuovimen V, Sindet-Pedersen S, Christiansen JS: Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol 1998;30:351-356.
17. Warner JT, Bell W, Webb DK, Gregory JW: Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy. Arch Dis Child 1997;76:298-303.
18. Sklar CA, Mertens AC, Walter A, Mitchell D, Nesbit ME, O'Leary M, Hutchinson R, Meadows AT, Robison LL: Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol 2000;35:91-95.
19. Ross JA, Oeffinger KC, Davies SM, Mertens AC, Langer EK, Kiffmeyer WR, Sklar CA, Stovall M, Yasui Y, Robison LL: Genetic variations in the leptin receptor gene and obesity in survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2004;22:3558-3562.
20. Van Dongen-Melman JE, Hokken-Koelega AC, Hahlen K, De Groot A, Tromp CG, Egeler RM: Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res 1995;38:86-90.
21. Stallings VA, Vaisman N, Chan HSL, Weitzman SS, Clarke R, Pencharz PB: Energy metabolism in children with newly diagnosed acute lymphoblastic leukemia. Pediatr Res 1989;26:154-157.
22. Ahmed SF, Wallace WH, Kelnar CJ: An anthropometric study of children during intensive chemotherapy for acute lymphoblastic leukaemia. Horm Res 1997;48:178-183.
23. Sainsbury CPQ, Newcombe RG, Hughes IA: Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia. Arch Dis Child 1985;60:832-836.
24. Calzolari A, Baronci C, Biondi G: Evaluation of a group of leukaemic children 'off therapy' towards their inclusion in physical activities. Int J Sports Cardiol 1985;2:108-115.
25. Bond SA, Han AM, Wootton SA, Kohler JA: Energy intake and basal metabolic rate during maintenance chemotherapy. Arch Dis Child 1992;67:229-232.
26. Talvensaari KK, Lanning M, Tapanainen P, Knip M: Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. J Clin Endocrinol Metab 1996;81:3051-3055.
27. Considine RV, Sinha MK, Helman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
28. Casanueva FF, Dieguez C: Neuroendocrine regulation and action of leptin. Front Neuroendocrinol 1999;20:317-363.
29. Magni P, Motta M, Martini L: Leptin: a possible link between food intake, energy expenditure, and reproductive function. Regul Pept 2000;92:51-56.
30. Link K, Moell C, Garwicz S, Cavallin-Stahl E, Bjork J, Thilen U, Ahren B, Erfurth EM: Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. J Clin Endocrinol Metab 2004;89:5003-5012.
31. Davies JH, Evans BA, Jones E, Evans WD, Jenney ME, Gregory JW: Osteopenia, excess adiposity and hyperleptinaemia during 2 years of treatment for childhood acute lymphoblastic leukaemia without cranial irradiation. Clin Endocrinol (Oxf) 2004;60:358-365.
32. Marques RM, Marcondes E, Berquó E, Prani R, Yunes J: Crescimento e desenvolvimento pubertário em crianças e adolescentes brasileiros. II. Altura e Peso. São Paulo, Editora Brasileira de Ciências, 1982.
33. Crist WM, Smithson WA: The leukemias; in Behrman RE, Kliegman RM, Jenson HB (eds): Nelson Textbook of Pediatrics, ed 16. Philadelphia, Saunders, 2000, pp 1694-1698.
34. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-1243.
35. Reilly JJ, Ventham JC, Newell J, Aitchison T, Wallace WH, Gibson BE: Risk factors for excess weight gain in children treated for acute lymphoblastic leukemia. Int J Obs Relat Metab Disord 2000;24:1537-1541.
36. Bouchard C, Perusse L: Genetics of obesity. Annu Rev Nutr 1993;3:337-354.
37. Pratley RE: Gene-environment interactions in the pathogenesis of type 2 diabetes mellitus: lessons learned from the Pima Indians. Proc Nutr Soc 1998;57:175-181.
38. O'Dea K, White N, Sinclair A: An investigation of nutrition-related risk factors in an isolated Aboriginal community in northern Australia: advantages of a traditionally-orientated life style. Med J Aust 1988;148:177-180.
39. O'Dea K: Marked improvement in carbohydrate and lipid metabolism in diabetic Australian aborigines after temporary reversion to traditional lifestyle. Diabetes 1983;33:596-603.
40. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE: Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 2003;88:611-616.
41. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, Rubin P: Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328:87-94.
42. Motta LACR, Martinelli C, Motta LDC, Abrahão AL, Farage Filho M, Gagliardi ART: Efeitos tardios na função hipotá lamohipófise após tratamento de tumores parasselares. Arq Neuro-Psiquiatr 1991;49:299-306.
43. Elimam A, Lindgren AC, Norgren S, Kamel A, Skwirut C, Bang P, Marcus C: Growth hormone treatment downregulates serum leptin levels in children independent of changes in body mass index. Hormone Res 1999;52:66-72.
44. Niswender KD, Baskin DG, Schwartz MW: Insulin and its evolving partnership with leptin in the hypothalamic control of energy homeostasis. Trends Endocrinol Metab 2004;15:362-369.
45. Lustig RH, Rose SR, Burghen GA, Velasquez-Myeyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE: Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by somatostatin agonist. J Pediatr 1999;135:142-144.
46. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW: Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes 2000;49:1525-1533.
47. Carantoni M, Abbasi F, Azhar S, Chen Y-D, Klebanov M, Wang P-W, Wamerdam F, Reaven GM: Plasma leptin concentrations do not appear to decrease insulin-mediated glucose disposal or glucose-stimulated insulin secretion in women with normal glucose tolerance. Diabetes 1998;47:244-247.
48. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF: Acute and chronic effects of insulin on leptin production in humans. Diabetes 1996;45:699-701.
49. Bates SH, Meyers MG: The role of leptin receptor signaling in feeding and neuroendocrine function. Trends Endocrinol Metab 2003;14:447-452.
50. Hirschler V, Aranda C, Calcagno Mde L, Maccalini G, Jadzinsky M: Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med 2005;159:740-744.
51. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ: Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468.
52. Lee S, Bacha F, Arslanian SA: Waist circumference, blood pressure, and lipid components of the metabolic syndrome. J Pediatr 2006;149:809-816.
53. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J: The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb 2005;12:295-300.